| |
Rx Communications Group to Host Panel Discussion for Biotechnology Executives on Communicating with the Media
- Panel featuring esteemed reporters to be held at Biotech Showcase 2011 -
NEW YORK, NY – January 4, 2011 – Rx Communications Group, LLC will host a panel discussion dedicated to better preparing biotechnology executives for media interviews with financial as well as trade journalists. The event will be held at Biotech Showcase™ 2011 taking place in San Francisco on Tuesday, January 11, 2011 from 8:00 am to 9:00 am, PT. The discussion will focus on media interview preparation and understanding the differing needs of financial reporters versus trade reporters.
"This will be a dynamic and interactive panel discussion to help biotech CEOs understand the unique needs of different types of reporters in order to achieve an optimal response," said Sara Jane Demy, Principal of Demy-Colton Life Science Advisors and co-developer of Biotech Showcase™ 2011. "Our panelists are known for their skillful analysis and intelligent reporting on the hottest biotech issues and often write on potential investment ideas. Each will share their insights, views and philosophies on how to communicate your story to your best advantage."
The panel titled "Influence the Press and Improve Your Bottom Line: Understand the Needs of Scientific vs. Financial Reporters and Use that Knowledge to Your Advantage" will feature the following experts:
Kimberly Ha, Global Editor of Pharmawire
Kimberly Ha is the Global Editor for Pharmawire, part of the Mergermarket Group. She has a BA in psychology from New York University, with a concentration in neuroscience and has been with Mergermarket since 2005, covering healthcare. She started out as a financial journalist in Hong Kong, covering live M&A deals, before moving to New York to join Pharmawire in 2007. Kimberly generates daily breaking news, and market moving scoops. Her articles have also appeared in AsiaMoney and Hong Kong Magazine; previously she was a court reporter for the Hong Kong Government.
Gene Marcial, Financial Columnist
Gene Marcial writes the "Inside Wall Street" column for DailyFinance; it previously ran for 28 years on BusinessWeek. Prior to joining BusinessWeek, Gene wrote the columns "Heard on the Street" and "Abreast of the Market”: for The Wall Street Journal. His column aims to give the small investor access to information normally privy to corporate insiders, and major investment houses. He is the acclaimed author of Gene Marcial's 7 Commandments of Stock Investing (FT Press, 2008), and Secrets of the Street, The Dark Side of Making Money (McGraw-Hill, 1995).
Moderators
Melody Carey and Rhonda Chiger, Co-founders of Rx Communications Group, LLC; Formed in 2000, Rx Communications is celebrating a decade of providing award-winning communications counsel to the life science and healthcare industries.
About Biotech Showcase™
Now in its third year, Biotech Showcase™ will feature corporate presentations by 195 innovative life sciences companies to an audience of public and private investors, business development executives and professional advisors who are interested in investment opportunities and collaboration during the course of the world's largest annual healthcare investor conference. The Biotech Showcase™ was co-founded by Demy-Colton Life Science Advisors and EBD Group, two organizations that have a long and successful history building programs that meet the needs of the life sciences industry.
About Rx Communications Group
Rx Communications is an award-winning financial communications firm specializing in the life sciences and healthcare industries. Rx provides investor relations, public relations and corporate communications counsel to private and public companies, worldwide. Every client account is staffed with senior level professionals enabling Rx to offer emerging companies the level of expertise that large agencies typically provide to major companies. Rx designs, implements and manages full-service programs, as well as transaction-oriented assignments. Rx is well versed in IPOs, secondary offerings, PIPEs, venture rounds and mergers and acquisitions -- all complementing the ongoing work Rx performs on behalf of clients. For additional information please visit www.RxIR.com.
Contact:
Eric Goldman
VP of Public Relations
917-322-2563
egoldman@rxir.com |
|
